Company Quick10K Filing
Axim Biotechnologies
S-1 2021-05-14 Public Filing
10-Q 2021-03-31 Filed 2021-05-24
10-K 2020-12-31 Filed 2021-04-15
10-Q 2020-09-30 Filed 2020-11-20
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-08
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-15
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-04-14
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-03-04
10-Q 2013-09-30 Filed 2013-11-18
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-17
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-17
8-K 2020-07-21
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-05-06
8-K 2020-03-27
8-K 2020-03-17
8-K 2020-01-03
8-K 2019-12-16
8-K 2019-07-02
8-K 2019-05-31
8-K 2019-04-19
8-K 2019-04-02
8-K 2019-02-20
8-K 2019-01-15
8-K 2019-01-02
8-K 2018-11-30
8-K 2018-09-10
8-K 2018-08-21
8-K 2018-05-07
8-K 2018-04-05
8-K 2018-03-30

Axim Biotechnologies Financials

AXIM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2339281914010950661195436324,1043,0822,0586321,8062,6622,2081,167
Accounts Receivable1015202015111339
Inventory2359641793107885466
PP&E16111110966543
Assets728758681331269691571,0627382361,8258254,4143,3222,1927922,0893,0182,8822,377
Accounts Payable6
Long-Term Debt462,818
Liabilities627749561381361371421511,2511,3191,2872,5883,7217,8428,1748,4776,9948,1718,3059,0438,554
Stockholders' Equity1010912-5-11-40-51-94-189-581-1,052-763-2,896
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue151515-2111111022194101561793403
Cost of Revenue3339-1213488326
Gross Profit-11-202815313577
R&D13314063633517351533992427
SG&A1615131745111283153765605475871,773857764
Tax0000000000
Net Income-1-02-17-6-300-43-139-392-507-1,704-524-565-1,642-1,438-1,334-2,343-1,805-864
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating6-3611-5-20-4-299-466-581-1,017-1,016-729-1,150-1,751
Cash Investing0-500000000000177
Cash Financing10150500650-4665003,940-6-81,585696533